Testicular Diseases: Clinical Trials

64 trials for Testicular Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

64 completed. 64 Phase 2, 8 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 264Completed 64
Phase 18Completed 8
Phase 32Completed 2

Follow Testicular Diseases: new trials by email Literature Review of Testicular Diseases trials Research Report on Testicular Diseases

Trials (filtered) newest first · largest first

All 64 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)
Pub2Post - Prostate Cancer (Adenocarcinoma), Bladder Cancer
Phase 2CompletedUniversity of Southern California1202025-01-162026-05-06
Short-term Testosterone Replacement in Testicular Cancer Survivors
Androgel (Testosterone gel), Placebo gel - Testicular Cancer
Phase 2CompletedUniversity Medical Center Groningen322018-12-212024-07-30
Avelumab in Refractory Testicular Germ Cell Cancer.
Avelumab - Testicular Neoplasms, Neoplasms, Germ Cell and Embryonal
Phase 2CompletedNational Cancer Institute, Slovakia82017-11-152019-03-05
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
Durvalumab, Tremelimumab, Poly-ICLC - Head and Neck Squamous Cell Carcinoma, Breast Cancer
Phase 1 / Phase 2CompletedLudwig Institute for Cancer Research582016-12-282022-12-02
Study of Testosterone vs Placebo in Testicular Cancer Survivors
Testosterone, Placebos - Metabolic Syndrome, Testicular Cancer
Phase 2 / Phase 3CompletedMikkel Bandak692016-11-012020-03-06
Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer
Veliparib, Gemcitabine, Carboplatin - Testicular Cancer
Phase 2CompletedNational Cancer Institute, Slovakia152016-08-012021-03-03
Pazopanib in Advanced and Cisplatin-resistant Germ Cell Tumors
Pazopanib - Germ Cell Tumors, Measurable Disease
Phase 2CompletedFondazione IRCCS Istituto Nazionale dei Tumori, Milano432013-05-172021-05-14
Brentuximab Vedotin (SGN-35) as Salvage Treatment for CD30-positive Germ Cell Tumors
Brentuximab Vedotin - Germ Cell Cancer
Phase 2CompletedFondazione Michelangelo92013-05-012018-02-07
Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors
Fosaprepitant, Dexamethasone, 5HT3 - Chemotherapy-Induced Nausea and Vomiting
Phase 2CompletedLawrence Einhorn652013-01-012016-05-25
Caudal Versus Intravenous Dexmedetomidine for Supplementation of Caudal Analgesia in Children
Caudal Dexmedetomidine, Intravenous Dexmedetomidine, Placebo - Inguinal Hernia, Cryptorchidism
Phase 2CompletedYao Yusheng902012-10-012018-11-15
Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer
Everolimus - Testicular Cancer, Germ Cell Cancer
Phase 2CompletedHannover Medical School252010-11-012015-02-25
Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer
PD-0332991 - Adult Solid Tumor, Adenocarcinoma of the Colon
Phase 2CompletedAbramson Cancer Center at Penn Medicine3042009-10-012021-03-11
The Addition of Clonidine to 0.2% Ropivacaine for Wound Instillation After Minor Lower Abdominal Surgery in Children
clonidine - Hernia, Inguinal, Hydrocele
Phase 2CompletedChildren's Hospital of Eastern Ontario1202009-09-012015-02-20
High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors
Gemcitabine, Docetaxel, Melphalan - Testicular Cancer
Phase 2CompletedM.D. Anderson Cancer Center642009-06-022024-08-26
Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors
Alvocidib Hydrochloride, Fluorouracil, Leucovorin Calcium - Recurrent Extragonadal Seminoma, Recurrent Malignant Extragonadal Germ Cell Tumor
Phase 2CompletedNational Cancer Institute (NCI)362009-06-012017-03-10
Androgen for Leydig Cell Proliferation
Testosterone undecanoate, Castor Oil - Klinefelter Syndrome, Hypergonadotropic Hypogonadism
Phase 2 / Phase 3CompletedUniversity of Roma La Sapienza562009-06-012018-09-25
Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary
Bevacizumab, Laboratory Biomarker Analysis - Malignant Ovarian Epithelial Tumor, Ovarian Granulosa Cell Tumor
Phase 2CompletedNational Cancer Institute (NCI)362008-09-222019-07-23
Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant
ondansetron, survey administration, management of therapy complications - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 2CompletedFred Hutchinson Cancer Center492008-08-082017-05-23
Dye Assisted Lymphatic Sparing Subinguinal Varicocelectomy
without dye varicocelectomy - Varicocele
Phase 2CompletedMansoura University802008-01-012010-12-14
Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
Carboplatin, Filgrastim, Ifosfamide - Childhood Extracranial Germ Cell Tumor, Childhood Extragonadal Malignant Germ Cell Tumor
Phase 2CompletedChildren's Oncology Group202007-11-052018-08-29

Showing 20 of 64. Sign in to see all of them.

Narrower conditions

Testicular Neoplasms (59)  ·  Testicular Germ Cell Tumor (29)  ·  Ovarian Neoplasms (27)  ·  Teratoma (19)  ·  Carcinoma, Embryonal (15)  ·  Breast Neoplasms (14)  ·  Endodermal Sinus Tumor (14)  ·  Neuroblastoma (14)  ·  Burkitt Lymphoma (13)  ·  Carcinoma, Ovarian Epithelial (12)  ·  Hodgkin Disease (12)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (12)  ·  Lymphoma, B-Cell, Marginal Zone (12)  ·  Lymphoma, Follicular (12)  ·  Lymphoma, Large B-Cell, Diffuse (12)

Broader conditions

Endocrine System Diseases (64)  ·  Genital Diseases (64)  ·  Genital Diseases, Male (64)  ·  Male Urogenital Diseases (64)  ·  Urogenital Diseases (64)  ·  Gonadal Disorders (63)  ·  Endocrine Gland Neoplasms (61)  ·  Genital Neoplasms, Male (61)  ·  Neoplasms by Site (61)  ·  Urogenital Neoplasms (61)  ·  Neoplasms (56)  ·  Neoplasms by Histologic Type (46)  ·  Female Urogenital Diseases (40)  ·  Female Urogenital Diseases and Pregnancy Complications (40)

Interventions

Carboplatin (15)  ·  Etoposide (13)  ·  Filgrastim (12)  ·  Paclitaxel (12)  ·  Ifosfamide (11)  ·  Cisplatin (8)  ·  Peripheral Blood Stem Cell Transplantation (7)  ·  Bleomycin (4)  ·  Gemcitabine (4)  ·  Thiotepa (4)  ·  Cyclophosphamide (3)  ·  Methylprednisolone (3)  ·  Oxaliplatin (3)  ·  etoposide phosphate (3)  ·  pegfilgrastim (3)

Sponsors

Memorial Sloan Kettering Cancer Center (11)  ·  Fred Hutchinson Cancer Center (7)  ·  National Cancer Institute (NCI) (4)  ·  Children's Oncology Group (2)  ·  European Organisation for Research and Treatment of Cancer - EORTC (2)  ·  Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (2)  ·  Medical Research Council (2)  ·  National Cancer Institute, Slovakia (2)  ·  University of Southern California (2)  ·  AHS Cancer Control Alberta (1)  ·  Abramson Cancer Center at Penn Medicine (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Cambridge University Hospitals NHS Foundation Trust (1)  ·  Cancer Treatment Centers of America (1)  ·  Case Comprehensive Cancer Center (1)

Countries

United States (43)  ·  Italy (6)  ·  United Kingdom (5)  ·  Canada (4)  ·  France (3)  ·  Germany (3)  ·  Netherlands (3)  ·  Slovakia (3)  ·  Switzerland (3)  ·  Australia (2)  ·  Belgium (2)  ·  Denmark (2)  ·  Puerto Rico (2)  ·  Austria (1)  ·  China (1)

Top investigators

Robert J. Motzer, MD (4)  ·  Andrea Necchi, MD (2)  ·  Brian H. Kushner, MD (2)  ·  Darren Feldman, MD (2)  ·  Gnanamba V. Kondagunta, MD (2)  ·  Alessandro M Gianni, MD (1)  ·  Alexander McEwan, MD (1)  ·  Anastasios Raptis, MD (1)  ·  Andrea Isidori, MD, PhD (1)  ·  Andrea Lenzi, MD (1)  ·  Barry L. Gause, MD (1)  ·  Carlos Rodriguez-Galindo (1)  ·  Claudio Viscoli, MD (1)  ·  Craig L Slingluff, Jr., MD (1)  ·  Darren Feldman (1)

Results publications

PMID 11919245, PMID 15999102, PMID 15999362, PMID 16688776, PMID 17194908, PMID 17290059, PMID 19547919, PMID 19841031, PMID 20194867, PMID 21875697, PMID 24894084, PMID 25001888, PMID 25344361, PMID 26199392, PMID 26838019, PMID 28673265, PMID 30232558, PMID 30302881, PMID 31532522, PMID 32641862, PMID 32692450, PMID 34052929, PMID 34223605, PMID 35514022, PMID 35701334

NIH funding

P30CA008748 (5), U10CA027469 (2), U10CA098543 (2), U10CA180868 (2), 2009 (1), N01CM00071 (1), N01CM62206 (1), P30CA006516 (1), P30CA033572 (1), P30CA043703 (1), U01CA062491 (1), U01CA062505 (1), U01CA069856 (1), U01CA069912 (1), U01CA099168 (1)